Can Teladoc Stock Bounce Back in 2025?

Back in 2020, Teladoc Health (NYSE: TDOC) was a market darling. The company's business was well adapted to survive -- and even thrive -- amid the worst of the pandemic. Its stock price soared as a result. What a difference a few years can make. Due to various issues, Teladoc's shares have been in free fall since 2021. However, the company hasn't given up. The telemedicine specialist is actively trying to turn the tide. Could 2025 be the year Teladoc finally pulls that off? Let's find out.Teladoc underwent an important change last year. In June, it appointed a new CEO, Charles Divita. Clearly, things were no longer working under the former head of the company. Divita has the difficult task of righting the ship, something that isn't easy to do in a mere year and a half. However, several things could help the company in 2025. Let's consider three.First, Teladoc could improve its existing product offering. The company serves customers through its integrated care unit, its BetterHelp therapy segment, and a chronic care unit.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool